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•  Yellow	  fever	  virus	  (YFV)	  
• Hemorrhagic	  disease	  
• Mosquito-­‐borne	  
•  Vaccine	  available	  but	  no	  treatment	  
•  Tested	  Lycorine	  against	  YFV	  
•  Chikungunya	  Virus	  (CHIKV)	  
•  Causes	  arthriEc	  and	  joint	  pain	  
• Mosquito-­‐borne	  	  	  
• No	  treatment	  available	  
•  Tested	  Silymarin	  against	  CHIKV	  
•  Lycorine	  (AcEve)	  
•  CPE	  results	  
•  EC50=	  .33	  µg/ml	  	  
•  IC50=	  58	  µg/ml	  	  
•  SI=180	  
•  EC90=	  .42	  µg/ml	  	  
•  New	  SI=	  136	  
•  Silymarin	  (Marginally	  AcEve)	  
•  CPE	  results	  
•  EC50=	  87	  µg/ml	  	  
•  IC50=	  190	  µg/ml	  	  




•  Lycorine	  was	  highly	  acEve	  against	  YFV,	  while	  Silymarin	  was	  marginally	  
effecEve	  against	  CHIKV.	  	  
•  PotenEal	  problems	  with	  the	  cell	  controls	  in	  HUH7	  cells:	  
–  Not	  a	  confluent	  monolayer	  to	  begin	  with.	  
–  This	  could	  have	  skewed	  our	  results	  yielding	  a	  higher	  SI	  than	  is	  correct	  
(we	  will	  repeat	  the	  study	  to	  verify	  results).	  
Future	  Research	  
•  An	  SI	  of	  >10	  warrants	  further	  tesEng.	  
•  Silymarin	  does	  not	  warrant	  further	  tesEng.	  
•  Lycorine	  warrants	  further	  tesEng.	  
– Repeat	  CPE	  inhibiEon	  assay	  
– Repeat	  VYR	  assay	  










•  Cytopathic	  effect	  (CPE)	  inhibiEon	  assay	  	  
– Lycorine	  and	  Silymarin	  were	  purchased	  as	  solid	  compound	  from	  Sigma-­‐Aldrich	  
Chemical	  Company.	  
– Compounds	  are	  prepared	  at	  2X	  the	  desired	  starEng	  concentraEon	  in	  appropriate	  
diluent	  (Saline	  for	  Lycorine	  and	  10%	  DMSO	  for	  Silymarin).	  
– Half-­‐log	  diluEons	  of	  the	  compound	  are	  prepared	  in	  cell	  culture	  medium	  
– The	  compound	  diluEons	  are	  added	  to	  cell	  monolayers	  (Vero	  76	  or	  HUH7	  cells)	  in	  a	  96-­‐
well	  plate	  (within	  the	  orange/green	  and	  yellow	  boxes	  in	  Fig.	  3).	  
– An	  equal	  volume	  of	  virus	  (17D	  YFV	  or	  LR2006	  OPY1	  CHIKV)	  was	  added	  immediately	  
aher	  addiEon	  of	  compound	  at	  a	  concentraEon	  that	  would	  result	  in	  complete	  CPE	  of	  
virus	  controls	  (in	  the	  orange,	  red,	  and	  green	  boxes	  on	  Fig.	  3).	  
– Plates	  are	  observed	  for	  CPE	  visually	  and	  results	  recorded.	  
– Aher	  visual	  read,	  plates	  are	  stained	  with	  neutral	  red	  (NR)	  for	  a	  dye	  uptake	  assay	  to	  
determine:	  
• The	  50%	  effecEve	  concentraEon	  (EC50)	  or	  concentraEon	  of	  the	  compound	  needed	  to	  
prevent	  50%	  of	  the	  cells	  from	  dying	  (Orange	  and	  green	  boxes	  in	  Fig.	  3).	  
• The	  50%	  inhibitory	  concentraEons	  (IC50)	  or	  concentraEon	  of	  the	  compound	  that	  results	  
in	  toxicity	  to	  the	  50%	  of	  the	  cells	  (Yellow	  boxes	  in	  Fig.	  3).	  
• The	  selecEve	  index	  (SI)	  is	  calculated	  by	  dividing	  IC50/EC50	  and	  gives	  an	  indicaEon	  of	  
efficacy.	  	  
• A	  compound	  with	  an	  SI>10	  is	  considered	  acEve	  and	  warrants	  further	  tesEng.	  
•  Virus	  yield	  reducEon	  (VYR)	  assay	  
– Plates	  were	  prepared	  as	  above.	  
– When	  CPE	  was	  observed,	  cells	  were	  frozen.	  
– Virus	  infected	  wells	  with	  the	  same	  concentraEon	  of	  compound	  were	  pooled	  and	  
Etered	  on	  HUH7	  cells.	  
– CPE	  was	  recorded	  at	  an	  appropriate	  Eme	  depending	  on	  the	  virus	  used.	  
– The	  EC90	  of	  the	  compound,	  or	  concentraEon	  of	  compound	  required	  to	  reduce	  virus	  by	  
1	  log10,	  was	  determined.	  
•  Controls	  included	  Infergen,	  6-­‐Aza,	  Ribavirin	  
Fig.1.	  Structure	  of	  Lycorine	  
(3)	  
Fig.2.	  Structure	  of	  Silymarin	  
Fig.3.	  NR	  stained	  CPE	  assay	  with	  Lycorine	  (leh)	  starEng	  at	  100	  µg/ml	  	  and	  Ribavirin	  as	  control	  
(right).	  Yellow-­‐toxicity	  controls,	  orange-­‐	  YFV	  infected	  and	  treated	  with	  Lycorine,	  blue-­‐	  cell	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